Published in Arthritis Res Ther on December 07, 2011
Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome (2013) 1.58
Can NMR solve some significant challenges in metabolomics? J Magn Reson (2015) 0.98
Biomarkers in nephrology: Core Curriculum 2013. Am J Kidney Dis (2013) 0.91
The kidney biopsy in lupus nephritis: is it still relevant? Rheum Dis Clin North Am (2014) 0.89
Metabolomics in rheumatic diseases: desperately seeking biomarkers. Nat Rev Rheumatol (2016) 0.88
What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol (2015) 0.84
Systemic lupus erythematosus diagnostics in the 'omics' era. Int J Clin Rheumtol (2013) 0.84
Connective tissue diseases: Promises and challenges of metabolomics in SLE. Nat Rev Rheumatol (2016) 0.75
A systems approach to renal inflammation in SLE. Clin Immunol (2016) 0.75
Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis. PLoS One (2016) 0.75
Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets. Organogenesis (2013) 0.75
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics. Diseases (2016) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Podocyte biology and response to injury. J Am Soc Nephrol (2002) 3.25
Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int (1984) 3.10
Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med (1983) 2.38
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Acidosis in experimental electrolyte depletion. Clin Sci (Lond) (1955) 2.11
Development of the renal glomerulus: good neighbors and good fences. Development (2008) 1.79
Statistical significance analysis of nuclear magnetic resonance-based metabonomics data. Anal Biochem (2010) 1.50
Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) (2009) 1.50
Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res (2010) 1.50
Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med (1987) 1.42
Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. J Rheumatol (2004) 1.30
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum (2009) 1.28
Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis (2007) 1.18
Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. J Rheumatol (2005) 1.17
Longterm followup of childhood lupus nephritis. J Rheumatol (2002) 1.16
Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) (2008) 1.15
Quantification and statistical significance analysis of group separation in NMR-based metabonomics studies. Chemometr Intell Lab Syst (2011) 1.07
THE REPRODUCIBILITY OF SEMIQUANTITATIVE ANALYSES OF RENAL HISTOLOGY. Nephron (1964) 1.06
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma. Nat Rev Nephrol (2009) 1.05
Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp (2003) 1.04
Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations. Lupus (2007) 1.04
Review: Microfluidic applications in metabolomics and metabolic profiling. Anal Chim Acta (2009) 0.99
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol Renal Physiol (2000) 0.99
Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol (2007) 0.98
Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol (2006) 0.98
Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease. BMC Gastroenterol (2010) 0.97
Clinicopathological correlations of paediatric lupus nephritis. Pediatr Nephrol (2006) 0.96
Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine. Clin Exp Pharmacol Physiol (2004) 0.95
Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med (2008) 0.95
Metabolomics for early detection of drug-induced kidney injury: review of the current status. Bioanalysis (2009) 0.94
Membranous lupus nephritis. Lupus (2005) 0.94
Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int (1989) 0.92
Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus (2003) 0.91
Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges. Ther Drug Monit (2008) 0.90
Reliability of histologic scoring for lupus nephritis: a community-based evaluation. Ann Intern Med (1993) 0.86
Metabolism of [35S]taurine in man. J Nutr (1975) 0.86
Taurine concentrations in serum of critically injured patients and age- and sex-matched healthy control subjects. Am J Clin Nutr (1990) 0.85
Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis. Ren Fail (2008) 0.85
Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs (2008) 0.84
Plasma and urine taurine levels in vegans. Am J Clin Nutr (1988) 0.84
An overview of divalent cation and citrate handling by the kidney. Nephron Physiol (2004) 0.84
Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol (2004) 0.83
Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. Nephrol Dial Transplant (2009) 0.83
Current therapies for lupus nephritis in an ethnically heterogeneous cohort. J Rheumatol (2009) 0.81
Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using (1)H NMR spectroscopy. Clin Chem Lab Med (2009) 0.81
Renal citrate metabolism and urinary citrate excretion in the infant rat. Kidney Int (2000) 0.79
Biomarkers for renal disease in childhood. Curr Rheumatol Rep (2009) 0.79
Taurine: A therapeutic agent in experimental kidney disease. Amino Acids (1996) 0.78
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.99
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet (2006) 6.98
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med (2005) 6.83
Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet (2006) 5.36
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A (2007) 4.71
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (2011) 4.57
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56
Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet (2004) 4.46
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study. Crit Care Med (2009) 4.30
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med (2012) 4.15
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum (2013) 4.02
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med (2015) 3.63
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care (2007) 3.29
The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med (2011) 3.20
Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care (2007) 3.19
Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol (2011) 3.17
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med (2012) 3.14
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum (2007) 3.12
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int (2008) 3.12
Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol (2010) 3.03
NMR structure determination for larger proteins using backbone-only data. Science (2010) 3.00
NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) 2.99
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol (2012) 2.97
Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2004) 2.96
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med (2009) 2.94
Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol (2004) 2.91
Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90
Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum (2004) 2.88
The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant (2009) 2.73
Differential gene expression following early renal ischemia/reperfusion. Kidney Int (2003) 2.60
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum (2007) 2.56
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med (2006) 2.53
Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol (2006) 2.48
Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med (2009) 2.45
IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol (2009) 2.43
Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med (2011) 2.41
Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens (2006) 2.34
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med (2008) 2.32
Hydroxychloroquine in lupus pregnancy. Arthritis Rheum (2006) 2.27
Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum (2006) 2.27
Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum (2009) 2.20
NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome. Pediatr Nephrol (2011) 2.19
Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg (2009) 2.19
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol (2006) 2.18
New biomarkers of acute kidney injury. Crit Care Med (2008) 2.11
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol (2006) 2.09
Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis Rheumatol (2015) 2.07
Acute kidney injury in childhood: should we be worried about progression to CKD? Pediatr Nephrol (2010) 2.00
An NMR approach to structural proteomics. Proc Natl Acad Sci U S A (2002) 1.95
Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet (2011) 1.92
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol (2010) 1.89
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int (2011) 1.88
Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) (2006) 1.87
Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol (2013) 1.82
Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 1.81
Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet (2008) 1.80
Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther (2006) 1.78
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int (2004) 1.76
Solution NMR structure of the iron-sulfur cluster assembly protein U (IscU) with zinc bound at the active site. J Mol Biol (2004) 1.76
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum (2005) 1.75
Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. J Rheumatol (2013) 1.75
Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2011) 1.72
Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol (2010) 1.69
Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol (2007) 1.69
International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum (2004) 1.66
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum (2012) 1.66
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum (2007) 1.66
Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr (2011) 1.66
Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum (2008) 1.64
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum (2010) 1.63
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care (2009) 1.61
Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther (2003) 1.61
The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum (2005) 1.59
Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome (2013) 1.58
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology (Oxford) (2013) 1.58
Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet (2011) 1.57
Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int (2012) 1.55
Procoagulants and osteonecrosis. J Rheumatol (2003) 1.54
The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolism. J Biol Chem (2005) 1.52
Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol (2002) 1.51
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum (2011) 1.51
Statistical significance analysis of nuclear magnetic resonance-based metabonomics data. Anal Biochem (2010) 1.50